2m 2m 2m 2m 2m 2m 2m
Viking Therapeut (VKTX)
NASDAQ
$38.16+$0.04 (+0.12%)
Price as of Jul 14, 2026 5:14 AM EDT- $4.5BMarket Cap
- 20.52%1-Year Change
- BiotechnologyIndustry
Viking Therapeut (VKTX)
$38.16+$0.04 (+0.12%)
VKTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $38.12 | ||
Change | -$0.74 (-1.90%) | ||
Open | $38.01 | ||
High | $38.70 | ||
Low | $37.11 | ||
Previous Close | $38.86 | ||
Volume | 2,006,679 | ||
30-Day Average Volume | 3,073,276 | ||
1-Week Change | -1.52% | ||
1-Month Change | 32.59% | ||
1-Year Change | 20.52% | ||
3-Year Change | 142.19% | ||
5-Year Change | 547.20% | ||
Fundamentals | |||
Shares Outstanding | 116.1M | ||
Total Assets | $608.2M | ||
Market Cap | $4.5B | ||
Enterprise Value | $4.4B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$158.3M | ||
Free Cash Flow | -$114.0M | ||
EBIT | -$158.3M | ||
EBITDA | -$158.3M | ||
Net Working Capital | $501.9M | ||
EPS | -$1.37 | ||
Enterprise Value/EBITDA | -28 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 9 | ||
P/E | -28 | ||
PEG | -34 | ||
Price/Free Cash Flow | -40 | ||
Price/Operating Cash Flow | -40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue